Werkgroep Cardiologische centra Nederland

AEGIS-II (Recruiting)

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Medicine
CSL112
Population
ASCVD
Phase
III
Starting year
2017

Director of Study

drs. B.J.B. Hamer (Cardioloog)
Amersfoort, Meander Medisch Centrum